|
ZNF79 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1436999999902E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.776330E-04 |
| Normal-vs-Stage2 |
2.322000E-01 |
| Normal-vs-Stage3 |
3.76460000000023E-05 |
| Normal-vs-Stage4 |
1.12519999984073E-08 |
| Stage1-vs-Stage2 |
1.493020E-01 |
| Stage1-vs-Stage3 |
1.578950E-01 |
| Stage1-vs-Stage4 |
1.233850E-04 |
| Stage2-vs-Stage3 |
3.623700E-02 |
| Stage2-vs-Stage4 |
1.962560E-04 |
| Stage3-vs-Stage4 |
1.219910E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.10080000000645E-05 |
| Normal-vs-AfricanAmerican |
3.863200E-03 |
| Normal-vs-Asian |
8.216300E-03 |
| Caucasian-vs-AfricanAmerican |
5.233400E-01 |
| Caucasian-vs-Asian |
5.478600E-01 |
| AfricanAmerican-vs-Asian |
3.264800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.388200E-04 |
| Normal-vs-Female |
1.7050399999996E-05 |
| Male-vs-Female |
8.100400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.75380000000081E-05 |
| Normal-vs-Age(41-60Yrs) |
7.235400E-04 |
| Normal-vs-Age(61-80Yrs) |
6.23319999999428E-05 |
| Normal-vs-Age(81-100Yrs) |
5.358400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.197600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.844800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.299830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.940450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.484230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.405600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.541900E-02 |
| Classical-VS-Follicular |
7.089000E-01 |
| Classical-VS-Other |
8.488800E-01 |
| Classical-VS-Normal |
1.211300E-04 |
| Tall-VS-Follicular |
1.567880E-02 |
| Tall-VS-Other |
5.010800E-01 |
| Tall-VS-Normal |
2.15699999999153E-05 |
| Follicular-VS-Other |
7.824200E-01 |
| Follicular-VS-Normal |
5.195100E-03 |
| Other-VS-Normal |
1.286590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.181400E-03 |
| Normal-vs-N1 |
2.92079999997252E-06 |
| N0-vs-N1 |
1.759470E-03 |
|
|
